Difference of Procalcitonin Levels in Gram-Positive and Gram-Negative Bacterial Sepsis Patients of Indonesia Army Central Hospital Gatot Soebroto in 2016
Downloads
Introduction: Procalcitonin is known as a marker of infection and indicator for severity of infections. In sepsis, elevated procalcitonin levels in blood have a significant value that can be used as a sepsis biomarker. The aim of this study was to determine the mean difference of procalcitonin levels in Gram-positive and Gram-negative bacterial sepsis patients.
Methods: This study used quantitative method with cross sectional approach. The sample of this study were bacterial sepsis patients of Indonesia Army Central Hospital Gatot Soebroto in 2016 which were divided into two groups: Gram-positive and Gram-negative bacterial sepsis patients with the number of each group was 30 samples. The data were analyzed by using independent t test.
Results: This study showed that mean levels of procalcitonin in Gram-positive bacterial sepsis patients was 6.47 ng/ml and Gram-negative was 66.04 ng/ml. There was a significant difference between mean levels of procalcitonin in Gram-positive and Gram-negative bacterial sepsis patients of Indonesia Army Central Hospital Gatot Soebroto in 2016 with p value = 0.000 (p < 0.05).
Conclusion: The mean difference of procalcitonin levels in Gram-negative bacterial sepsis patients were higher than Gram-positive bacterial sepsis patients, because Gram-negative bacteria have lipopolysaccharide which is a strong immunostimulator and increases TNF-α production higher than Gram-positive bacteria.
Kochanek KD, Murphy SL, Xu J, Tejada-Vera. Deaths: final data for 2014. Natl Vital Stat Rep 2016; 65(4): 1-12.
Tambajong RN, Lalenoh DC, Kumaat L. Profile of sepsis patients in ICU RSUP Prof. Dr. R. D. Kandou Manado December 2014 – November 2015 period. Universitas Sam Ratulangi; 2016.
Chalupa P, Beran O, Herwald H, Kasprikova N, Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011; 39: 411–417.
Chaudhury A, Sachin Sumant GL, Jayaprada R, Kalawat U, Ramana BV. Procalcitonin in sepsis and bacterial infections. J Clin Sci Res 2013; 2: 216-224.
Coriejati, Iqbal M, Pranggono EH. Bacterial pattern and patient's age on procalcitonin in community and hospital acquired pneumonia. Indonesian Journal of Clinical Pathology and Medical Laboratory 2015; 2(2): 153-157.
Christ-Crain M, Opal SM. Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia. Crit Care 2010; 14(1): 203.
Soreng K, Levy R. Procalcitonin: an emerging biomarker of bacterial sepsis. Clinical Microbiology Newsletter 2011; 33(22): 171-177.
Nasa P, Juneja D, Singh O. Severe sepsis and septic shock in the elderly: an overview. World J Crit Care Med 2012; 1(1): 23-30.
Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41 Suppl 7:S504-12.
De Gaudio AR, Rinaldi S, Chelazzi C, Borracci T. Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations', Curr Drug Targets 2009; 10(1): 60-70.
Herran-Monge R, Mmuriel-Bombin A, Garcia-Garcia MM, Merino-Garcia PA, Martinez-Barrios M, Andaluz D, et al. Epidemiology and changes in mortality of sepsis after the implementation of surviving sepsis campaign guidelines. Journal of Intensive Care Medicine 2017: 1-11.
Kleinschmidt S, Huygens, Faoagali J, Rathnayake IU, Hafner LM. Staphylococcus epidermidis as a cause of bacteremia. Future Microbiol 2015; 10(11): 1859-1879.
Kordekag A. Concentrations of procalcitonin and C-reactive protein, white blood cell count, and the immature-to-total neutrophil ratio in the blood of neonates with nosocomial infections: Gram-negative bacilli vs coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis 2011; 30(3): 455-457.
Guo SY, Zhou Y, Hu QF, Yao J, Wang H. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis. Am J Med Sci 2015; 349(6): 499-504.
Hsieh PF, Lin TL, Yang FL, Wu MC, Pan YJ, Wu SH, et al. Lipopolysaccharide O1 antigen contribues to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. PLoS One 2012; 7(3): e33155.
Evrard B, Balestrino D, Dosgilbert A, Bouya-Gachancard J, Charbonnel N, Forestier C, et al. Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun 2010; 78.
Holden VI. The impact of siderophores and iron acquisition on klebsiella pneumoniae pathogenesis. University of Michigan; 2016.
Li S, Rong H, Guo Q. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci 2016; 21(39).
Leli, C, Ferranti M, Moretti A, Al Dhahab ZS, Cenci E, Mencacci A. Procalcitonin levels in gram-positive, gram-negative, and fungal bloodstream infections. Disease Markers 2015; 2015.
Brooks GF, Carroll KC, Butel JS, Morse SA, Mietzner TA. Jawetz, Melnick & Adelberg's Medical Microbiology: 26th Edition. The McGraw-Hill Companies; 2010.
Suharto (ed). Infectious disease in Indonesia, current and future solutions, 2nd edition. 2011. Surabaya.
Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. The American Society of Hematology 2007; 9(4): 1574-1583.
Kumar S, Ingle H, Prasad DV, Kumar H. Recognition of bacterial infection by innate immune sensors. Crit Rev Microbiol 2013; 39(3): 229-246.
Gotts JE, Matthay MA. Sepsis: patophysiology and clinical management. BMJ 2016; 353: i1585.
Guo B, Cheng, G. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK', The Journal of Biological Chemistry 2007; 282(16): 11817-11826.
Li S, Rong H, Guo Q. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci 2016; 21(39).
Copyright (c) 2022 Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
